Zwi Berneman

Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study

Lucien Noens, Marie-Anne van Lierde, R. De Bock et al. · Blood · 2009 · 615 citations · Full text

Medicine, Hematology, Oncology +7

Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells

Viggo Van Tendeloo, Peter Ponsaerts, Filip Lardon et al. · Blood · 2001 · 458 citations · Full text

Pharmacy, Biomedical Engineering, Immunology +17

Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccination

Viggo Van Tendeloo, Ann Van de Velde, Ann Van Driessche et al. · Proceedings of the National Academy of Sciences · 2010 · 372 citations · Full text

Medicine, Immunology, Oncology +17

Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.

Bob Löwenberg, Stefan Suciu, E Archimbaud et al. · Journal of Clinical Oncology · 1998 · 288 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus.

Zwi Berneman, Dharam V. Ablashi, G Li et al. · Proceedings of the National Academy of Sciences · 1992 · 255 citations

Life Sciences, Immunology, Microbiology +13